{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:27:54Z","timestamp":1792319274384,"version":"4.4.0"},"reference-count":208,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS), or Lou Gehrig\u2019s disease, is a motor neuron disease. In ALS, upper and lower motor neurons in the brain and spinal cord progressively degenerate during the course of the disease, leading to the loss of the voluntary movement of the arms and legs. Since its first description in 1869 by a French neurologist Jean-Martin Charcot, the scientific discoveries on ALS have increased our understanding of ALS genetics, pathology and mechanisms and provided novel therapeutic strategies. The goal of this review article is to provide a comprehensive summary of the recent findings on ALS mechanisms and related therapeutic strategies to the scientific audience. Several highlighted ALS research topics discussed in this article include the 2023 FDA approved drug for SOD1 ALS, the updated C9orf72 GGGGCC repeat-expansion-related mechanisms and therapeutic targets, TDP-43-mediated cryptic splicing and disease markers and diagnostic and therapeutic options offered by these recent discoveries.<\/jats:p>","DOI":"10.3390\/cells13110888","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T11:03:47Z","timestamp":1716375827000},"page":"888","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Updates on Disease Mechanisms and Therapeutics for Amyotrophic Lateral Sclerosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5237-2576","authenticated-orcid":false,"given":"Lien","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Center for NeuroGenetics, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Department of Neuroscience, College of Medicine, University of Florida, Gainesville, FL 32610, USA"},{"name":"Genetics Institute, University of Florida, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: An update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/17482961003610853","article-title":"The sex ratio in amyotrophic lateral sclerosis: A population based study","volume":"11","author":"Manjaly","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Trojsi, F., D\u2019Alvano, G., Bonavita, S., and Tedeschi, G. (2020). Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103647"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/21678421.2022.2059380","article-title":"Prevalence of amyotrophic lateral sclerosis in the United States using established and novel methodologies, 2017","volume":"24","author":"Mehta","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study","volume":"82","author":"Calvo","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis\u2014Frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/jnnp-2017-315667","article-title":"Examining the language and behavioural profile in FTD and ALS-FTD","volume":"88","author":"Saxon","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1007\/s00415-023-11832-w","article-title":"Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: A prospective longitudinal cohort study","volume":"270","author":"Dubbioso","year":"2023","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/brain\/awad426","article-title":"Skin innervation across amyotrophic lateral sclerosis clinical stages: New prognostic biomarkers","volume":"147","author":"Nolano","year":"2023","journal-title":"Brain"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00115-017-0293-3","article-title":"Causes of death in amyotrophic lateral sclerosis. Results from the Rhineland-Palatinate ALS registry","volume":"88","author":"Wolf","year":"2017","journal-title":"Nervenarzt"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: A cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"907122","DOI":"10.3389\/fnagi.2022.907122","article-title":"C9orf72-Related Neurodegenerative Diseases: From Clinical Diagnosis to Therapeutic Strategies","volume":"14","author":"Zampatti","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41598-021-03891-8","article-title":"SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity","volume":"12","author":"Berdynski","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp.2010.207464","article-title":"An estimate of amyotrophic lateral sclerosis heritability using twin data","volume":"81","author":"Fang","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","article-title":"Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis","volume":"76","author":"Ryan","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Trabjerg, B.B., Garton, F.C., van Rheenen, W., Fang, F., Henderson, R.D., Mortensen, P.B., Agerbo, E., and Wray, N.R. (2020). ALS in Danish Registries: Heritability and links to psychiatric and cardiovascular disorders. Neurol. Genet., 6.","DOI":"10.1212\/NXG.0000000000000398"},{"key":"ref_19","first-page":"181","article-title":"Risk factors for amyotrophic lateral sclerosis","volume":"7","author":"Ingre","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000443146","article-title":"Environmental Risk Factors and Amyotrophic Lateral Sclerosis: An Umbrella Review and Critical Assessment of Current Evidence from Systematic Reviews and Meta-Analyses of Observational Studies","volume":"46","author":"Belbasis","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tzeplaeff, L., Wilfling, S., Requardt, M.V., and Herdick, M. (2023). Current State and Future Directions in the Therapy of ALS. Cells, 12.","DOI":"10.3390\/cells12111523"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(01)00661-X","article-title":"Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new HPLC method with coulometric detection in a large cohort of patients","volume":"193","author":"Bensimon","year":"2002","journal-title":"J. Neurol. Sci."},{"key":"ref_24","unstructured":"Oh, S., Agrawal, S., Sabir, S., and Taylor, A. (2024). StatPearls, StatPearls Publishing."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/21678421.2023.2239292","article-title":"ALSUntangled #71: Nuedexta","volume":"25","author":"Sun","year":"2024","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Cunha-Oliveira, T., Montezinho, L., Mendes, C., Firuzi, O., Saso, L., Oliveira, P.J., and Silva, F.S.G. (2020). Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxid. Med. Cell. Longev., 2020.","DOI":"10.1155\/2020\/5021694"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn Superoxide-Dismutase Gene Are Associated with Familial Amyotrophic-Lateral-Sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Eleutherio, E.C.A., Magalhaes, R.S.S., Brasil, A.D., Neto, J.R.M., and Paranhos, L.D. (2021). SOD1, more than just an antioxidant. Arch. Biochem. Biophys., 697.","DOI":"10.1016\/j.abb.2020.108701"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molcel.2013.08.038","article-title":"SOD1 as a Molecular Switch for Initiating the Homeostatic ER Stress Response under Zinc Deficiency","volume":"52","author":"Homma","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1038\/ncomms4446","article-title":"Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance","volume":"5","author":"Tsang","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ni.1633","article-title":"Superoxide dismutase 1 regulates caspase-1 and endotoxic shock","volume":"9","author":"Meissner","year":"2008","journal-title":"Nat. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8292","DOI":"10.1073\/pnas.91.17.8292","article-title":"Superoxide-Dismutase-1 with Mutations Linked to Familial Amyotrophic-Lateral-Sclerosis Possesses Significant Activity","volume":"91","author":"Borchelt","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.410430319","article-title":"Mutations in all five exons of may cause ALS","volume":"43","author":"Shaw","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20738","DOI":"10.1038\/s41598-020-77716-5","article-title":"Premature termination codons in causing Amyotrophic Lateral Sclerosis are predicted to escape the nonsense-mediated mRNA decay","volume":"10","author":"Guissart","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.1038\/s41598-022-16871-3","article-title":"Cellular analysis of SOD1 protein-aggregation propensity and toxicity: A case of ALS with slow progression harboring homozygous mutation","volume":"12","author":"Sawamura","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10072-009-0125-8","article-title":"Heterozygous SOD1 D90A mutation presenting as slowly progressive predominant upper motor neuron amyotrophic lateral sclerosis","volume":"30","author":"Luigetti","year":"2009","journal-title":"Neurol. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41431-021-00975-x","article-title":"SOD1 D91A variant in the southernmost tip of Europe: A heterozygous ALS patient resident on the island of Gozo","volume":"30","author":"Wismayer","year":"2022","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gagliardi, D., Ripellino, P., Meneri, M., Del Bo, R., Antognozzi, S., Comi, G.P., Gobbi, C., Ratti, A., Ticozzi, N., and Silani, V. (2023). Clinical and molecular features of patients with amyotrophic lateral sclerosis and mutations: A monocentric study. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1169689"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1073\/pnas.1312245111","article-title":"Intercellular propagated misfolding of wild-type Cu\/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms","volume":"111","author":"Grad","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","article-title":"Triad of TDP43 control in neurodegeneration: Autoregulation, localization and aggregation","volume":"22","author":"Tziortzouda","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor-Neuron Degeneration in Mice That Express a Human Cu,Zn Superoxide-Dismutase Mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbrainres.2004.07.002","article-title":"Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS","volume":"130","author":"Alexander","year":"2004","journal-title":"Mol. Brain Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/ng0596-43","article-title":"Motor neurons in Cu\/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury","volume":"13","author":"Reaume","year":"1996","journal-title":"Nat. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00415-022-11489-x","article-title":"A novel homozygous p.Ser69Pro mutation causes severe young-onset ALS with decreased enzyme activity","volume":"270","author":"Fahmy","year":"2023","journal-title":"J. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJMc1905039","article-title":"Phenotype in an Infant with Homozygous Truncating Mutation","volume":"381","author":"Andersen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/21678421.2023.2189925","article-title":"A novel homozygous loss-of-function variant in SOD1 causing progressive spastic tetraplegia and axial hypotonia","volume":"24","author":"Pekbilir","year":"2023","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1074\/jbc.M210326200","article-title":"Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents\u2014A comparative analysis","volume":"278","author":"Vickers","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","article-title":"An antisense oligonucleotide against delivered intrathecally for patients with familial amyotrophic lateral sclerosis: A phase 1, randomised, first-in-man study","volume":"12","author":"Miller","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2003715","article-title":"Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"383","author":"Miller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1007\/s00415-022-11055-5","article-title":"Plasma neurofilament light chain as a biomarker of Alzheimer\u2019s disease in Subjective Cognitive Decline and Mild Cognitive Impairment","volume":"269","author":"Giacomucci","year":"2022","journal-title":"J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1136\/jnnp-2022-abn2.6","article-title":"Tofersen in Adults with Sod1-Als: Phase 3 Valor Trial and Open-Label Extension Results","volume":"93","author":"Shaw","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Wiesenfarth, M., Dorst, J., Brenner, D., Elmas, Z., Parlak, O., Uzelac, Z., Kandler, K., Mayer, K., Weiland, U., and Herrmann, C. (2024). Effects of tofersen treatment in patients with SOD1-ALS in a \u201creal-world\u201d setting\u2014A 12-month multicenter cohort study from the German early access program. EClinicalMedicine, 69.","DOI":"10.1016\/j.eclinm.2024.102495"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s13311-022-01286-9","article-title":"Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic Variant Carriers: The ATLAS Study","volume":"19","author":"Benatar","year":"2022","journal-title":"Neurotherapeutics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1056\/NEJMoa2005056","article-title":"Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS","volume":"383","author":"Mueller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng0693-175","article-title":"Fusion of the Dominant-Negative Transcription Regulator Chop with a Novel Gene Fus by Translocation T(12-16) in Malignant Liposarcoma","volume":"4","author":"Rabbitts","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/363640a0","article-title":"Fusion of Chop to a Novel Rna-Binding Protein in Human Myxoid Liposarcoma","volume":"363","author":"Crozat","year":"1993","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"24731","DOI":"10.1074\/jbc.M113.497974","article-title":"The RNA-binding Protein Fused in Sarcoma (FUS) Functions Downstream of Poly(ADP-ribose) Polymerase (PARP) in Response to DNA Damage","volume":"288","author":"Mastrocola","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kato, M., and McKnight, S.L. (2021). The low-complexity domain of the FUS RNA binding protein self-assembles via the mutually exclusive use of two distinct cross-\u03b2 cores. Proc. Natl. Acad. Sci. USA, 118.","DOI":"10.1073\/pnas.2114412118"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ishigaki, S., Masuda, A., Fujioka, Y., Iguchi, Y., Katsuno, M., Shibata, A., Urano, F., Sobue, G., and Ohno, K. (2013). Erratum: Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions (vol 2, 529, 2012). Sci. Rep., 3.","DOI":"10.1038\/srep03301"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1073\/pnas.1506282112","article-title":"FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP","volume":"112","author":"Yu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/srep00603","article-title":"Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain","volume":"2","author":"Rogelj","year":"2012","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"18459","DOI":"10.1074\/jbc.RA120.013801","article-title":"FUS contributes to mTOR-dependent inhibition of translation","volume":"295","author":"Julien","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Fujino, Y., Ueyama, M., Ishiguro, T., Ozawa, D., Ito, H., Sugiki, T., Murata, A., Ishiguro, A., Gendron, T., and Mori, K. (2023). FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in-linked ALS\/FTD. eLife, 12.","DOI":"10.7554\/eLife.84338"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nn.3514","article-title":"Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons","volume":"16","author":"Wang","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.1523\/JNEUROSCI.0172-14.2014","article-title":"FUS is Phosphorylated by DNA-PK and Accumulates in the Cytoplasm after DNA Damage","volume":"34","author":"Deng","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/nar\/gkt835","article-title":"PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS\/TLS to sites of oxidative DNA damage","volume":"42","author":"Rulten","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2014.78","article-title":"The role of gene variants in neurodegenerative diseases","volume":"10","author":"Deng","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chen, C., Ding, X.F., Akram, N., Xue, S., and Luo, S.Z. (2019). Fused in Sarcoma: Properties, Self-Assembly and Correlation with Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081622"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis","volume":"323","author":"Kwiatkowski","year":"2009","journal-title":"Science"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"550.e1","DOI":"10.1016\/j.neurobiolaging.2009.12.020","article-title":"mutations in sporadic amyotrophic lateral sclerosis","volume":"32","author":"Lai","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.brainres.2016.03.036","article-title":"Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis","volume":"1647","author":"Shang","year":"2016","journal-title":"Brain Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Grassano, M., Brodini, G., De Marco, G., Casale, F., Fuda, G., Salamone, P., Brunetti, M., Sbaiz, L., Gallone, S., and Cugnasco, P. (2022). Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis. Neurol. Genet., 8.","DOI":"10.1212\/NXG.0000000000200011"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ana.22051","article-title":"FUS-Immunoreactive Inclusions Are a Common Feature in Sporadic and Non-SOD1 Familial Amyotrophic Lateral Sclerosis","volume":"67","author":"Deng","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1093\/brain\/awz217","article-title":"Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis","volume":"142","author":"Tyzack","year":"2019","journal-title":"Brain"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/brain\/awp214","article-title":"A new subtype of frontotemporal lobar degeneration with FUS pathology","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40478-019-0658-x","article-title":"ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles","volume":"7","author":"An","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.15252\/embj.201592559","article-title":"Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss","volume":"35","author":"Sendscheid","year":"2016","journal-title":"EMBO J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"25266","DOI":"10.1074\/jbc.M113.492017","article-title":"Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice","volume":"288","author":"Shelkovnikova","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI72723","article-title":"ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects","volume":"124","author":"Qiu","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40478-015-0202-6","article-title":"FUS\/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis","volume":"3","author":"Kino","year":"2015","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Garone, M.G., Birsa, N., Rosito, M., Salaris, F., Mochi, M., de Turris, V., Nair, R.R., Cunningham, T.J., Fisher, E.M.C., and Morlando, M. (2021). ALS-related FUS mutations alter axon growth in motoneurons and affect HuD\/ELAVL4 and FMRP activity. Commun. Biol., 4.","DOI":"10.1038\/s42003-021-02538-8"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.stemcr.2023.12.007","article-title":"Mutations in FUS lead to synaptic dysregulation in ALS-iPSC derived neurons","volume":"19","author":"Shum","year":"2024","journal-title":"Stem Cell Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/glia.23298","article-title":"Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha","volume":"66","author":"Kia","year":"2018","journal-title":"Glia"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-022-00591-3","article-title":"FUS-ALS hiPSC-derived astrocytes impair human motor units through both gain-of-toxicity and mechanisms","volume":"18","author":"Dittlau","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stemcr.2022.01.004","article-title":"Homozygous ALS-linked P525L mutations cell-autonomously perturb transcriptome profile and chemoreceptor signaling in human iPSC microglia","volume":"17","author":"Kerk","year":"2022","journal-title":"Stem Cell Rep."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tejido, C., Pakravan, D., and Van Den Bosch, L. (2021). Potential Therapeutic Role of HDAC Inhibitors in FUS-ALS. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.686995"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/WCO.0000000000000959","article-title":"Ataxin-2 gene: A powerful modulator of neurological disorders","volume":"34","author":"Paucar","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ostrowski, L.A., Hall, A.C., and Mekhail, K. (2017). Ataxin-2: From RNA Control to Human Health and Disease. Genes, 8.","DOI":"10.3390\/genes8060157"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature09320","article-title":"Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS","volume":"466","author":"Elden","year":"2010","journal-title":"Nature"},{"key":"ref_96","first-page":"842","article-title":"The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia","volume":"60","author":"Geschwind","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/brain\/awac167","article-title":"ATXN2 intermediate expansions in amyotrophic lateral sclerosis","volume":"145","author":"Glass","year":"2022","journal-title":"Brain"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","article-title":"trinucleotide repeat length correlates with risk of ALS","volume":"51","author":"Sproviero","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"231.e7","DOI":"10.1016\/j.neurobiolaging.2018.09.009","article-title":"ATXN2 intermediate repeat expansions influence the clinical phenotype in frontotemporal dementia","volume":"73","author":"Rubino","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-018-0547-8","article-title":"Interrupted CAG expansions in gene expand the genetic spectrum of frontotemporal dementias","volume":"6","author":"Fournier","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Borrego-Hern\u00e1ndez, D., V\u00e1zquez-Costa, J.F., Dom\u00ednguez-Rubio, R., Exp\u00f3sito-Bl\u00e1zquez, L., Aller, E., Padr\u00f3-Miquel, A., Garc\u00eda-Casanova, P., Colomina, M.J., Mart\u00edn-Arriscado, C., and Osta, R. (2024). Intermediate Repeat Expansion in the Gene as a Risk Factor in the ALS and FTD Spanish Population. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020356"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","article-title":"ALS-Associated Ataxin 2 PolyQ Expansions Enhance Stress-Induced Caspase 3 Activation and Increase TDP-43 Pathological Modifications","volume":"32","author":"Hart","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/hmg\/dds479","article-title":"Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis","volume":"22","author":"Farg","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1038\/s41467-023-42147-z","article-title":"Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins","volume":"14","author":"Zeballos","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/01.wnl.0000200048.53766.b4","article-title":"A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia","volume":"66","author":"Morita","year":"2006","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/brain\/awl030","article-title":"Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3","volume":"129","author":"Vance","year":"2006","journal-title":"Brain"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of Causes Chromosome 9p-Linked FTD and ALS","volume":"72","author":"Mackenzie","year":"2011","journal-title":"Neuron"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A Hexanucleotide Repeat Expansion in Is the Cause of Chromosome 9p21-Linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajhg.2021.03.011","article-title":"30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?","volume":"108","author":"Depienne","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/B978-0-444-63233-3.00009-9","article-title":"Repeat expansion diseases","volume":"147","author":"Paulson","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Breevoort, S., Gibson, S., Figueroa, K., Bromberg, M., and Pulst, S. (2022). Expanding Clinical Spectrum of C9ORF72-Related Disorders and Promising Therapeutic Strategies: A Review. Neurol. Genet., 8.","DOI":"10.1212\/NXG.0000000000000670"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Gendron, T.F., and Petrucelli, L. (2018). Disease Mechanisms of C9ORF72 Repeat Expansions. Cold Spring Harb. Perspect. Med., 8.","DOI":"10.1101\/cshperspect.a024224"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/s41598-017-02364-1","article-title":"Age-related penetrance of the C9orf72 repeat expansion","volume":"7","author":"Murphy","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/jmg-2023-109580","article-title":"Reduced penetrance of gene variants causing amyotrophic lateral sclerosis","volume":"61","author":"Douglas","year":"2024","journal-title":"J. Med. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1001\/jamaneurol.2019.3924","article-title":"Survival and Prognostic Factors in C9orf72 Repeat Expansion Carriers: A Systematic Review and Meta-analysis","volume":"77","author":"Glasmacher","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","article-title":"C9orf72-mediated ALS and FTD: Multiple pathways to disease","volume":"14","author":"Balendra","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2016.04.004","article-title":"There has been an awakening: Emerging mechanisms of mutations in FTD\/ALS","volume":"1647","author":"Gitler","year":"2016","journal-title":"Brain Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1779.e5","DOI":"10.1016\/j.neurobiolaging.2014.01.016","article-title":"Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion","volume":"35","author":"Waite","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Pang, W., and Hu, F. (2023). C9ORF72 suppresses JAK-STAT mediated inflammation. iScience, 26.","DOI":"10.1016\/j.isci.2023.106579"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jnc.15255","article-title":"Cellular and physiological functions of C9ORF72 and implications for ALS\/FTD","volume":"157","author":"Pang","year":"2021","journal-title":"J. Neurochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.aaf1064","article-title":"is required for proper macrophage and microglial function in mice","volume":"351","author":"Bogdanik","year":"2016","journal-title":"Science"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Atanasio, A., Decman, V., White, D., Ramos, M., Ikiz, B., Lee, H.C., Siao, C.J., Brydges, S., LaRosa, E., and Bai, Y. (2016). ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep., 6.","DOI":"10.1038\/srep23204"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Lopez-Herdoiza, M.B., Bauch\u00e9, S., Wilmet, B., Le Duigou, C., Roussel, D., Frah, M., B\u00e9al, J., Devely, G., Boluda, S., and Frick, P. (2023). C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice. Front. Cell. Neurosci., 17.","DOI":"10.3389\/fncel.2023.1155929"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-019-0685-7","article-title":"C9orf72 deficiency promotes motor deficits of a C9ALS\/FTD mouse model in a dose-dependent manner","volume":"7","author":"Shao","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41593-020-0619-5","article-title":"Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72","volume":"23","author":"Zhu","year":"2020","journal-title":"Nat. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat. Med."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Dane, T.L., Gill, A.L., Vieira, F.G., and Denton, K.R. (2023). Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity. Front. Cell. Neurosci., 17.","DOI":"10.3389\/fncel.2023.1134090"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.dnarep.2013.04.019","article-title":"Bidirectional transcription of trinucleotide repeats: Roles for excision repair","volume":"12","author":"Budworth","year":"2013","journal-title":"DNA Repair."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1093\/nar\/gkad403","article-title":"Conformational dynamics of RNA G4C2 and G2C4 repeat expansions causing ALS\/FTD using NMR and molecular dynamics studies","volume":"51","author":"Taghavi","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Conlon, E.G., Lu, L., Sharma, A., Yamazaki, T., Tang, T., Shneider, N.A., and Manley, J.L. (2016). The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. eLife, 5.","DOI":"10.7554\/eLife.17820"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acschemneuro.6b00348","article-title":"Structure and Dynamics of DNA and RNA Double Helices Obtained from the GGGGCC and CCCCGG Hexanucleotide Repeats That Are the Hallmark of C9FTD\/ALS Diseases","volume":"8","author":"Zhang","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","volume":"126","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Cesnik, A.B., Darovic, S., Mihevc, S.P., Stalekar, M., Malnar, M., Motaln, H., Lee, Y.B., Mazej, J., Pohleven, J., and Grosch, M. (2019). Nuclear RNA foci from expansion mutation form paraspeckle-like bodies. J. Cell Sci., 132.","DOI":"10.1242\/jcs.224303"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00401-015-1429-9","article-title":"Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy","volume":"130","author":"Higginbottom","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Parameswaran, J., Zhang, N.Y., Braems, E., Tilahun, K., Pant, D.C., Yin, K.A., Asress, S., Heeren, K., Banerjee, A., and Davis, E. (2023). Antisense, but not sense, repeat expanded RNAs activate PKR\/eIF2a-dependent ISR in FTD\/ALS. eLife, 12.","DOI":"10.7554\/eLife.85902"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fnins.2017.00711","article-title":"Unraveling the Role of RNA Mediated Toxicity of Repeats in C9-FTD\/ALS","volume":"11","author":"Kumar","year":"2017","journal-title":"Front. Neurosci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","article-title":"Non-ATG-initiated translation directed by microsatellite expansions","volume":"108","author":"Zu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional Translation of GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"ref_142","unstructured":"Gendron, T.F., Chew, J., Stankowski, J.N., Hayes, L.R., Zhang, Y.J., Prudencio, M., Carlomagno, Y., Daughrity, L.M., Jansen-West, K., and Perkerson, E.A. (2017). Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis. Sci. Transl. Med., 9."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"859","DOI":"10.15252\/emmm.201607486","article-title":"Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS\/FTD","volume":"9","author":"Lehmer","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1038\/s41467-022-30387-4","article-title":"Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS\/FTD","volume":"13","author":"Krishnan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s40478-018-0564-7","article-title":"Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease","volume":"6","author":"Sakae","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-neuro-070918-050405","article-title":"Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Goodman, L.D., and Bonini, N.M. (2019). Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS\/FTD. Prog. Neurobiol., 183.","DOI":"10.1016\/j.pneurobio.2019.101697"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aaa9344","article-title":"Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits","volume":"348","author":"Chew","year":"2015","journal-title":"Science"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","article-title":"Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy","volume":"14","author":"Chew","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.neuron.2015.10.027","article-title":"C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS\/FTD","volume":"88","author":"Bogdanik","year":"2015","journal-title":"Neuron"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","article-title":"C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS\/FTD","volume":"90","author":"Liu","year":"2016","journal-title":"Neuron"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neuron.2015.11.018","article-title":"Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice","volume":"88","author":"Peters","year":"2015","journal-title":"Neuron"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Schmitz, A., Pinheiro Marques, J., Oertig, I., Maharjan, N., and Saxena, S. (2021). Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS\/FTD. Front. Cell Neurosci., 15.","DOI":"10.3389\/fncel.2021.637548"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-022-30418-0","article-title":"Ribosome inhibition by C9ORF72-ALS\/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM","volume":"13","author":"Loveland","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Kriachkov, V., Ormsby, A.R., Kusnadi, E.P., McWilliam, H.E.G., Mintern, J.D., Amarasinghe, S.L., Ritchie, M.E., Furic, L., and Hatters, D.M. (2023). Arginine-rich C9ORF72 ALS proteins stall ribosomes in a manner distinct from a canonical ribosome-associated quality control substrate. J. Biol. Chem., 299.","DOI":"10.1101\/2022.02.09.479805"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.molcel.2017.02.013","article-title":"Phase Separation of Dipeptide Repeats Perturbs Stress Granule Dynamics","volume":"65","author":"Boeynaems","year":"2017","journal-title":"Mol. Cell"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41593-024-01589-4","article-title":"PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS\/FTD neurons","volume":"27","author":"Milioto","year":"2024","journal-title":"Nat. Neurosci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cell.2017.12.030","article-title":"In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment","volume":"172","author":"Guo","year":"2018","journal-title":"Cell"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1093\/hmg\/ddx350","article-title":"C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity","volume":"26","author":"Lee","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-022-02494-5","article-title":"PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in 72-ALS\/FTD","volume":"144","author":"Pilotto","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2017.07.029","article-title":"Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases","volume":"96","author":"Kim","year":"2017","journal-title":"Neuron"},{"key":"ref_162","first-page":"E4530","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Baughn","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of Toxicity from ALS\/FTD-Linked Repeat Expansions in Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41467-021-21112-8","article-title":"Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.omtn.2022.04.007","article-title":"Preclinical evaluation of WVE-004, aninvestigational stereopure oligonucleotide forthe treatment of C9orf72-associated ALS or FTD","volume":"28","author":"Liu","year":"2022","journal-title":"Mol. Ther-Nucl. Acids"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-021-01557-6","article-title":"Suppression of mutant expression by a potent mixed backbone antisense oligonucleotide","volume":"28","author":"Tran","year":"2022","journal-title":"Nat. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-023-02652-3","article-title":"GC targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS\/FTD induced pluripotent stem cell derived neurons","volume":"147","author":"Rothstein","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"687","DOI":"10.15252\/emmm.201607054","article-title":"Antibodies inhibit transmission and aggregation of poly-GA dipeptide repeat proteins","volume":"9","author":"Zhou","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.neuron.2019.11.007","article-title":"Antibody Therapy Targeting RAN Proteins Rescues C9 ALS\/FTD Phenotypes in Mouse Model","volume":"105","author":"Nguyen","year":"2020","journal-title":"Neuron"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Zhou, Q.H., Mareljic, N., Michaelsen, M., Parhizkar, S., Heindl, S., Nuscher, B., Farny, D., Czuppa, M., Schludi, C., and Graf, A. (2020). Active poly-GA vaccination prevents microglia activation and motor deficits in a mouse model. EMBO Mol. Med., 12.","DOI":"10.15252\/emmm.201910919"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/s41467-017-02200-0","article-title":"RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response","volume":"8","author":"Green","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41467-017-02495-z","article-title":"C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2\u03b1 phosphorylation","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Westergard, T., McAvoy, K., Russell, K., Wen, X.M., Pang, Y., Morris, B., Pasinelli, P., Trotti, D., and Haeusler, A. (2019). Repeat-associated non-AUG translation in C9orf72-ALS\/FTD is driven by neuronal excitation and stress. EMBO Mol. Med., 11.","DOI":"10.15252\/emmm.201809423"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"18591","DOI":"10.1073\/pnas.2005748117","article-title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in ALS\/FTD mice","volume":"117","author":"Zu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-017-02729-0","article-title":"repeat expansion causes vulnerability of motor neurons to Ca2+-permeable AMPA receptor-mediated excitotoxicity","volume":"9","author":"Selvaraj","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/hmg\/ddaa106","article-title":"Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in by CRISPR\/Cas9 genome editing using homology-directed repair","volume":"29","author":"Ababneh","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"5672","DOI":"10.1038\/s41598-022-07746-8","article-title":"Dual-gRNA approach with limited off-target effect corrects repeat expansion in vivo","volume":"12","author":"Piao","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1038\/s41467-022-33332-7","article-title":"CRISPR\/Cas9-mediated excision of ALS\/FTD-causing hexanucleotide repeat expansion in rescues major disease mechanisms in vivo and in vitro","volume":"13","author":"Meijboom","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nmeth.2857","article-title":"Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects","volume":"11","author":"Shen","year":"2014","journal-title":"Nat. Methods"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis","volume":"7","author":"Leverenz","year":"2008","journal-title":"Lancet Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Cook, C.N., Wu, Y.W., Odeh, H.M., Gendron, T.F., Jansen-West, K., del Rosso, G., Yue, M., Jiang, P.Z., Gomes, E., and Tong, J.M. (2020). poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med., 12.","DOI":"10.1126\/scitranslmed.abb3774"},{"key":"ref_183","first-page":"790","article-title":"Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS\/FTLD","volume":"26","author":"Khosravi","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B.K. (2019). Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13311-015-0351-0","article-title":"TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets (vol 12, pg 352, 2015)","volume":"12","author":"Scotter","year":"2015","journal-title":"Neurotherapeutics"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nn.2779","article-title":"Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43","volume":"14","author":"Polymenidou","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","article-title":"Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration","volume":"22","author":"Melamed","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1172\/JCI139741","article-title":"Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia","volume":"130","author":"Prudencio","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00401-023-02655-0","article-title":"Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer\u2019s disease","volume":"147","author":"Quadros","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Thornburg-Suresh, E.J.C., Richardson, J.E., and Summers, D.W. (2023). The Stathmin-2 membrane-targeting domain is required for axon protection and regulated degradation by DLK signaling. J. Biol. Chem., 299.","DOI":"10.1016\/j.jbc.2023.104861"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","article-title":"ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair","volume":"22","author":"Klim","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_193","first-page":"4031","article-title":"Loss of mouse function causes motor neuropathy (vol 110, pg 1671, 2022)","volume":"110","author":"Juan","year":"2022","journal-title":"Neuron"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Krus, K.L., Strickland, A., Yamada, Y., Devault, L., Schmidt, R.E., Bloom, A.J., Milbrandt, J., and DiAntonio, A. (2022). Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy. Cell Rep., 39.","DOI":"10.1101\/2022.03.13.484188"},{"key":"ref_195","first-page":"34","article-title":"Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation","volume":"27","author":"Presa","year":"2023","journal-title":"Nat. Neurosci."},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Theunissen, F., Anderton, R.S., Mastaglia, F.L., Flynn, L.L., Winter, S.J., James, I., Bedlack, R., Hodgetts, S., Fletcher, S., and Wilton, S.D. (2021). Novel Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.658226"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ng.442","article-title":"Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis","volume":"41","author":"Veldink","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.24198","article-title":"and Are Shared Risk Loci for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: A Genome-Wide Meta-Analysis","volume":"76","author":"Diekstra","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ng.3622","article-title":"Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis","volume":"48","author":"Shatunov","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/jamaneurol.2018.0372","article-title":"Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum","volume":"75","author":"Karch","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"630.e3","DOI":"10.1016\/j.neurobiolaging.2011.10.029","article-title":"UNC13A is a modifier of survival in amyotrophic lateral sclerosis","volume":"33","author":"Diekstra","year":"2012","journal-title":"Neurobiol. of Aging"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Manini, A., Casiraghi, V., Brusati, A., Maranzano, A., Gentile, F., Colombo, E., Bonetti, R., Peverelli, S., Invernizzi, S., and Gentilini, D. (2023). Association of the risk factor with survival and upper motor neuron involvement in amyotrophic lateral sclerosis. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1067954"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp-2022-330504","article-title":"in amyotrophic lateral sclerosis: From genetic association to therapeutic target","volume":"94","author":"Willemse","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ana.25841","article-title":"The Distinct Traits of the Polymorphism in Amyotrophic Lateral Sclerosis","volume":"88","author":"Tan","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3934\/Neuroscience.2023029","article-title":"Role of the UNC13 family in human diseases: A literature review","volume":"10","author":"Ansari","year":"2023","journal-title":"Aims Neurosci."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","article-title":"TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","article-title":"TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A","volume":"603","author":"Brown","year":"2022","journal-title":"Nature"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Koike, Y., Pickles, S., Estades Ayuso, V., Jansen-West, K., Qi, Y.A., Li, Z., Daughrity, L.M., Yue, M., Zhang, Y.J., and Cook, C.N. (2023). TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS\/FTD risk gene, UNC13A. PLoS Biol., 21.","DOI":"10.1371\/journal.pbio.3002028"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/888\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:46:04Z","timestamp":1760107564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/11\/888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":208,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["cells13110888"],"URL":"https:\/\/doi.org\/10.3390\/cells13110888","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}